Clinical Trial Update: Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of combining BL-8040 (motixafortide) with pembrolizumab in metastatic pancreatic adenocarcinoma has completed e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• BL-8040
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: BioLineRx, Ltd. | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-08-28